Assessing Long-Term Safety and Efficacy of Osilodrostat in Prior- and New-Use Patients with Endogenous Cushing's Syndrome: a 1-Year Real-World Interim Analysis of the Non-Interventional, Multinational LINC 6 Study
Endocrine Abstracts(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要